XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.23.2

Investments in Other Entities | 3 Months Ended
--- | ---
Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Investments in Other Entities | Investments in Other Entities Equity Method Investments in other entities – equity method consisted of the following (in thousands):
| December 31, 2022 |  | Initial Investment |  | Allocation of Income (Loss) |  |  |  | Funding |  |  |  | Distribution |  | March 31, 2023
LaSalle Medical Associates – IPA Line of Business | $ | 5,684 |  |  | $ | — |  |  | $ | 2,165 |  |  |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | 7,849 |
Pacific Medical Imaging & Oncology Center, Inc. | 1,878 |  |  | — |  |  | 8 |  |  |  |  | — |  |  |  |  | — |  |  | 1,886 |
531 W. College, LLC | 17,281 |  |  | — |  |  | (90) |  |  |  |  | — |  |  |  |  | — |  |  | 17,191 |
One MSO, LLC | 2,718 |  |  | — |  |  | 115 |  |  |  |  | — |  |  |  |  | — |  |  | 2,833 |
CAIPA MSO, LLC | 12,738 |  |  | — |  |  | 249 |  |  |  |  | — |  |  |  |  | — |  |  | 12,987 |
James Song, M.D., A Professional Corporation | — |  |  | 325 |  |  | 37 |  |  |  |  | — |  |  |  |  | — |  |  | 362 |
| $ | 40,299 |  |  | $ | 325 |  |  | $ | 2,484 |  |  |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | 43,108 |
LaSalle Medical Associates — IPA Line of Business LMA was founded by Dr. Albert Arteaga in 1996 and operates as an IPA delivering high-quality care. In September 2021, APC-LSMA sold 21.25% of its interest in LMA back to Dr. Arteaga for $6.4 million, which resulted in APC-LSMA owning a 25% interest in LMA as of March 31, 2023. APC accounts for its investment in LMA under the equity method as APC has the ability to exercise significant influence but not control over LMA’s operations. For the three months ended March 31, 2023 and 2022, APC recognized income from this investment of $2.2 million and $1.3 million, respectively, in the accompanying consolidated statements of income. The accompanying consolidated balance sheets include the related investment balances of $7.8 million and $5.7 million at March 31, 2023 and December 31, 2022, respectively. LMA’s summarized balance sheets at March 31, 2023 and December 31, 2022, and summarized statements of income for the three months ended March 31, 2023 and 2022, with respect to its IPA line of business are as follows (in thousands): Balance Sheets
| March 31, 2023 |  | December 31, 2022
| (unaudited) |  | (unaudited)
Assets |  |  |
Cash and cash equivalents | $ | 14,873 |  |  | $ | 15,671 |
Receivables, net | 12,526 |  |  | 5,064 |
Prepaid assets | 6,952 |  |  | 5,032 |
Loan receivable | 2,250 |  |  | 2,250 |
Restricted cash | 703 |  |  | 700 |
Total assets | $ | 37,304 |  |  | $ | 28,717 |
Liabilities and stockholders' equity |  |  |
Current liabilities | $ | 30,260 |  |  | $ | 30,331 |
Stockholders’ equity (deficit) | 7,044 |  |  | (1,614) |
Total liabilities and stockholders’ equity | $ | 37,304 |  |  | $ | 28,717 |
Statements of Income
| Three months ended March 31,
| 2023 |  | 2022
| (unaudited) |  | (unaudited)
Revenues | $ | 67,619 |  |  | $ | 67,566 |
Expenses | 58,964 |  |  | 61,786 |
Income from operations | 8,655 |  |  | 5,780 |
Other Income | 3 |  |  | — |
Net income | $ | 8,658 |  |  | $ | 5,780 |
Pacific Medical Imaging and Oncology Center, Inc. APC-LSMA and PMIOC entered into a share purchase agreement whereby APC-LSMA purchased a 40% ownership interest in PMIOC. Incorporated in California in 2004, PMIOC provides comprehensive diagnostic imaging services using state-of-the-art technology. PMIOC offers high-quality diagnostic services, such as MRI/MRA, PET/CT, CT, nuclear medicine, ultrasound, digital X-rays, bone densitometry, and digital mammography, at its facilities. APC accounts for its investment in PMIOC under the equity method of accounting as APC has the ability to exercise significant influence, but not control over PMIOC’s operations. For the three months ended March 31, 2023 and 2022, APC recognized income from this investment of approximately $8,000 and $6,700, respectively, in the accompanying consolidated statements of income. The accompanying consolidated balance sheets had investment balances of $1.9 million and $1.9 million at March 31, 2023 and December 31, 2022, respectively. 531 W. College LLC APC has a 50% ownership in 531 W. College LLC and accounts for its investment in 531 W. College, LLC under the equity method of accounting as APC has the ability to exercise significant influence, but not control over the operations of this joint venture. 531 W. College, LLC owns a former hospital campus in Los Angeles that is now leased to tenants. The investment is deemed Excluded Assets that are solely for the benefit of APC and its shareholders. For the three months ended March 31, 2023 and 2022, APC recognized a loss from this investment of $90,000 and $0.2 million, respectively, in the accompanying consolidated statements of income. The accompanying consolidated balance sheets include the related investment balances of $17.2 million and $17.3 million at March 31, 2023 and December 31, 2022, respectively. One MSO, LLC APC has a 50% interest in One MSO. One MSO owns an office building in Monterey Park, California that is leased to tenants, including NMM. For the three months ended March 31, 2023 and 2022, APC recognized income of $0.1 million and $0.1 million, respectively, in the accompanying consolidated statements of income. The accompanying consolidated balance sheets include the related investment balances of $2.8 million and $2.7 million at March 31, 2023 and December 31, 2022, respectively. CAIPA MSO, LLC In August 2021, ApolloMed purchased a 30% interest in CAIPA MSO, LLC for $11.7 million. CAIPA MSO is a New York-based management services organization affiliated with Chinese-American IPA d/b/a Coalition of Asian-American IPA (“CAIPA”), a leading independent practice association serving the greater New York City area. ApolloMed accounts for its investment in CAIPA MSO under the equity method of accounting as ApolloMed has the ability to exercise significant influence, but not control over CAIPA MSO’s operations. For the three months ended March 31, 2023 and 2022, ApolloMed recognized income from investment of $0.2 million and $0.1 million, respectively, in the accompanying consolidated statements of income. The accompanying consolidated balance sheets include the related investment balances of $13.0 million and $12.7 million as of March 31, 2023 and December 31, 2022, respectively. James Song, M.D., A Professional Corporation In January 2023, AP-AMH 2 purchased a 25% interest in James Song, M.D., a Professional Corporation (“Song PC”), a medical corporation located in Hacienda Heights, California. AP-AMH 2 accounts for its investment in Song PC under the equity method of accounting as AP-AMH 2 has the ability to exercise significant influence, but not control over Song PC’s operations. For the three months ended March 31, 2023, AP-AMH 2 recognized income of $37,000 in the accompanying consolidated statements of income. The accompanying consolidated balance sheets include the related investment balances of $0.4 million as of March 31, 2023. Investments in privately held entities that do not report net asset value MediPortal, LLC In May 2018, APC purchased 270,000 membership interests of MediPortal LLC, a New York limited liability company, for $0.4 million or $1.50 per membership interest, which represented an approximately 2.8% ownership interest. In connection with the initial purchase, APC received a five-year warrant to purchase an additional 270,000 membership interests. A five-year option to purchase an additional 380,000 membership interests and a five-year warrant to purchase 480,000 membership interests were contingent upon the portal completion date. However, APC did not exercise the option after completion of the portal. As APC does not have the ability to exercise significant influence, and lacks control over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. AchievaMed In July 2019, NMM and AchievaMed, Inc., a California corporation (“AchievaMed”), entered into an agreement in which NMM would purchase 50% of the aggregate shares of capital stock of AchievaMed over a period of time not to exceed five years. As a result of this transaction, NMM invested $0.5 million for a 10% interest. The related investment balance of $0.5 million is included in investments in privately held entities in the accompanying consolidated balance sheets as of March 31, 2023. As NMM does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income.

X
- Definition Equity Method And Other Equity Investments [Text Block] + References No definition available. + Details
Name: | ameh_EquityMethodAndOtherEquityInvestmentsTextBlock
Namespace Prefix: | ameh_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration